$BCLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BRAINSTORM CELL THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BRAINSTORM CELL THERAPEUTICS INC.. Get notifications about new insider transactions in BRAINSTORM CELL THERAPEUTICS INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2014 | BCLI | BRAINSTORM CELL TH ... | Sossover Liat | Chief Financial Off ... | Option Exercise | A | 0.18 | 100,000 | 18,000 | 100,000 | |
Apr 23 2013 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 130,000 | 0 | 498,333 | 368.3 K to 498.3 K (+35.29 %) |
Apr 23 2013 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | A | 0.15 | 150,000 | 22,500 | 150,000 | |
Apr 23 2013 | BCLI | BRAINSTORM CELL TH ... | Pinkas Alon | Director | Option Exercise | A | 0.15 | 130,000 | 19,500 | 130,000 | |
Apr 23 2013 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 180,000 | 27,000 | 180,000 | |
Apr 23 2013 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 130,000 | 0 | 490,000 | 360 K to 490 K (+36.11 %) |
Apr 23 2013 | BCLI | BRAINSTORM CELL TH ... | Israeli Avi | Director | Option Exercise | A | 0.00 | 166,666 | 0 | 166,666 | |
Sep 06 2012 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 180,000 | 27,000 | 180,000 | |
Sep 06 2012 | BCLI | BRAINSTORM CELL TH ... | Pinkas Alon | Director | Option Exercise | A | 0.15 | 130,000 | 19,500 | 130,000 | |
Sep 06 2012 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | A | 0.15 | 150,000 | 22,500 | 150,000 | |
Aug 03 2012 | BCLI | BRAINSTORM CELL TH ... | Harel Adrian | Chief Executive Off ... | Option Exercise | A | 0.26 | 70,000 | 18,200 | 70,000 | |
Aug 03 2012 | BCLI | BRAINSTORM CELL TH ... | Sossover Liat | Chief Financial Off ... | Option Exercise | A | 0.26 | 60,000 | 15,600 | 60,000 | |
Aug 03 2012 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 130,000 | 0 | 360,000 | 230 K to 360 K (+56.52 %) |
Aug 03 2012 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 130,000 | 0 | 368,333 | 238.3 K to 368.3 K (+54.55 %) |
Apr 17 2012 | BCLI | BRAINSTORM CELL TH ... | Israeli Avi | Director | Option Exercise | A | 0.00 | 166,666 | 0 | 166,666 | |
Dec 07 2011 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.26 | 98,333 | 25,144 | 230,000 | 328.3 K to 230 K (-29.95 %) |
Nov 30 2011 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.27 | 10,000 | 2,700 | 328,333 | 338.3 K to 328.3 K (-2.96 %) |
Oct 06 2011 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.30 | 95,000 | 28,852 | 338,333 | 433.3 K to 338.3 K (-21.92 %) |
Oct 06 2011 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.31 | 105,000 | 32,855 | 433,333 | 538.3 K to 433.3 K (-19.50 %) |
Aug 23 2011 | BCLI | BRAINSTORM CELL TH ... | Schor Chen | Director | Grant | A | 0.00 | 923,374 | 0 | 923,374 | 0 to 923.4 K |
Aug 16 2011 | BCLI | BRAINSTORM CELL TH ... | Harel Adrian | Acting Chief Execut ... | Option Exercise | A | 0.20 | 70,000 | 14,000 | 70,000 | |
Aug 12 2011 | BCLI | BRAINSTORM CELL TH ... | Harel Adrian | Acting Chief Execut ... | Option Exercise | A | 0.20 | 450,000 | 90,000 | 450,000 | |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 130,000 | 0 | 538,333 | 408.3 K to 538.3 K (+31.84 %) |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 108,333 | 0 | 408,333 | 300 K to 408.3 K (+36.11 %) |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.46 | 100,000 | 45,540 | 238,333 | 338.3 K to 238.3 K (-29.56 %) |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 130,000 | 0 | 338,333 | 208.3 K to 338.3 K (+62.40 %) |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 108,333 | 0 | 208,333 | 100 K to 208.3 K (+108.33 %) |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | Pinkas Alon | Director | Option Exercise | A | 0.15 | 130,000 | 19,500 | 130,000 | |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | Pinkas Alon | Director | Option Exercise | A | 0.15 | 50,000 | 7,500 | 50,000 | |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 180,000 | 27,000 | 180,000 | |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 108,333 | 16,250 | 108,333 | |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | A | 0.15 | 150,000 | 22,500 | 150,000 | |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | Friedman Mordechai | Director | Option Exercise | A | 0.15 | 16,667 | 2,500 | 16,667 | |
Jul 25 2011 | BCLI | BRAINSTORM CELL TH ... | Israeli Avi | Director | Option Exercise | A | 0.00 | 166,666 | 0 | 166,666 | |
Jul 14 2011 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 200,000 | 0 | 300,000 | 100 K to 300 K (+200.00 %) |
Jun 20 2011 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 0.28 | 100,000 | 28,000 | 300,000 | 200 K to 300 K (+50.00 %) | |
Jun 15 2011 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 0.27 | 100,000 | 27,380 | 100,000 | 0 to 100 K | |
Jun 15 2011 | BCLI | BRAINSTORM CELL TH ... | ACC International Holdings Ltd ... | Buy | P | 0.30 | 100,000 | 30,000 | 100,000 | 0 to 100 K | |
Jun 08 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.28 | 33,023 | 9,246 | 0 | 33 K to 0 (-100.00 %) |
May 19 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 10,250 | 3,075 | 33,032 | 43.3 K to 33 K (-23.68 %) |
May 19 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 61,400 | 18,432 | 43,282 | 104.7 K to 43.3 K (-58.65 %) |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.12 | 10,499,999 | 1,260,000 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.00 | 4,537,500 | 0 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 4,537,500 | 1,315,875 | 4,537,500 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.12 | 2,000,001 | 240,000 | 10,499,999 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.00 | 4,537,500 | 0 | 4,537,500 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 4,537,500 | 1,315,875 | 4,537,500 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.12 | 9,916,667 | 1,190,000 | 12,500,000 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.12 | 14,166,667 | 1,700,000 | 22,416,667 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 1,008,334 | 292,417 | 1,008,334 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | D | 0.36 | 1,008,334 | 363,000 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 3,529,166 | 1,023,458 | 3,529,166 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | D | 0.29 | 3,529,166 | 1,023,458 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 4,537,500 | 1,315,875 | 4,537,500 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | D | 0.29 | 4,537,500 | 1,315,875 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 2,016,667 | 584,833 | 2,016,667 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | D | 0.29 | 2,016,667 | 584,833 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.20 | 2,520,833 | 504,167 | 2,520,833 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | D | 0.20 | 2,520,833 | 504,167 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.20 | 7,562,500 | 1,512,500 | 7,562,500 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | D | 0.20 | 7,562,500 | 1,512,500 | 0 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.00 | 4,537,500 | 0 | 9,075,000 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.18 | 4,125,000 | 749,925 | 8,250,000 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.36 | 1,008,334 | 363,000 | 1,008,334 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 3,529,166 | 1,023,458 | 3,529,166 | |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | M | 0.12 | 10,499,999 | 1,260,000 | 29,006,924 | 18.5 M to 29 M (+56.74 %) |
Apr 28 2011 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | M | 0.18 | 4,125,000 | 749,925 | 18,506,925 | 14.4 M to 18.5 M (+28.68 %) |
Apr 25 2011 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 200,000 | 30,000 | 200,000 | |
Apr 14 2011 | BCLI | BRAINSTORM CELL TH ... | Sossover Liat | Chief Financial Off ... | Option Exercise | A | 0.18 | 400,000 | 72,000 | 400,000 | |
Apr 14 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 165,000 | 49,500 | 104,682 | 269.7 K to 104.7 K (-61.18 %) |
Apr 14 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 3,000 | 900 | 269,682 | 272.7 K to 269.7 K (-1.10 %) |
Apr 14 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Option Exercise | A | 0.15 | 200,000 | 30,000 | 200,000 | |
Apr 14 2011 | BCLI | BRAINSTORM CELL TH ... | Israeli Avi | Director | Option Exercise | A | 0.15 | 200,000 | 30,000 | 200,000 | |
Apr 11 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 5,000 | 1,500 | 272,682 | 277.7 K to 272.7 K (-1.80 %) |
Apr 06 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 97,966 | 29,498 | 277,682 | 375.6 K to 277.7 K (-26.08 %) |
Apr 06 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 6,500 | 1,950 | 375,648 | 382.1 K to 375.6 K (-1.70 %) |
Apr 04 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 7,354 | 2,206 | 382,148 | 389.5 K to 382.1 K (-1.89 %) |
Apr 04 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 20,000 | 6,000 | 389,502 | 409.5 K to 389.5 K (-4.88 %) |
Mar 24 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.30 | 43,630 | 13,089 | 409,502 | 453.1 K to 409.5 K (-9.63 %) |
Mar 16 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.31 | 40,400 | 12,322 | 453,132 | 493.5 K to 453.1 K (-8.19 %) |
Mar 14 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.31 | 50,000 | 15,500 | 493,532 | 543.5 K to 493.5 K (-9.20 %) |
Mar 10 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.31 | 50,000 | 15,500 | 543,532 | 593.5 K to 543.5 K (-8.42 %) |
Mar 10 2011 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.32 | 81,468 | 26,330 | 593,532 | 675 K to 593.5 K (-12.07 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.26 | 225,000 | 59,108 | 675,000 | 900 K to 675 K (-25.00 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Sell | S | 0.25 | 350,000 | 87,990 | 900,000 | 1.3 M to 900 K (-28.00 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.31 | 40,000 | 12,440 | 100,000 | 140 K to 100 K (-28.57 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.30 | 20,000 | 6,000 | 140,000 | 160 K to 140 K (-12.50 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.37 | 10,000 | 3,700 | 140,000 | 150 K to 140 K (-6.67 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.29 | 25,000 | 7,250 | 170,000 | 195 K to 170 K (-12.82 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.28 | 50,000 | 14,000 | 195,000 | 245 K to 195 K (-20.41 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.27 | 50,000 | 13,500 | 245,000 | 295 K to 245 K (-16.95 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Sell | S | 0.28 | 5,000 | 1,400 | 295,000 | 300 K to 295 K (-1.67 %) |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | Lion Moshe | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
Apr 30 2010 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
Apr 15 2010 | BCLI | BRAINSTORM CELL TH ... | Israeli Avi | Director | Option Exercise | A | 0.00 | 166,666 | 0 | 166,666 | |
Feb 23 2010 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Sell | S | 0.36 | 100,000 | 36,000 | 150,000 | 250 K to 150 K (-40.00 %) |
Feb 19 2010 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Option Exercise | M | 0.15 | 400,000 | 60,000 | 0 | |
Feb 19 2010 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Sell | S | 0.36 | 2,000 | 720 | 250,000 | 252 K to 250 K (-0.79 %) |
Feb 19 2010 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Sell | S | 0.36 | 140,000 | 50,400 | 252,000 | 392 K to 252 K (-35.71 %) |
Feb 19 2010 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Sell | S | 0.36 | 3,000 | 1,080 | 392,000 | 395 K to 392 K (-0.76 %) |
Feb 19 2010 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Sell | S | 0.36 | 5,000 | 1,800 | 395,000 | 400 K to 395 K (-1.25 %) |
Dec 15 2009 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
Jul 02 2009 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Option Exercise | A | 0.07 | 200,000 | 13,400 | 200,000 | |
Jul 02 2009 | BCLI | BRAINSTORM CELL TH ... | Efrati Abraham | Chief Executive Off ... | Option Exercise | A | 0.07 | 1,000,000 | 67,000 | 1,000,000 | |
Apr 03 2009 | BCLI | BRAINSTORM CELL TH ... | TAUB MALCOLM S | Director | Option Exercise | A | 0.10 | 100,000 | 10,000 | 100,000 | |
Aug 28 2008 | BCLI | BRAINSTORM CELL TH ... | Javitt Jonathan C | Director | Option Exercise | X | 0.01 | 1,000,000 | 10,000 | 0 | |
Aug 28 2008 | BCLI | BRAINSTORM CELL TH ... | Javitt Jonathan C | Director | Sell | S | 0.25 | 40,000 | 10,000 | 960,000 | 1000 K to 960 K (-4.00 %) |
Aug 28 2008 | BCLI | BRAINSTORM CELL TH ... | Javitt Jonathan C | Director | Buy | X | 0.01 | 1,000,000 | 10,000 | 960,000 | -40,000 to 960 K (-2,500.00 %) |
Apr 28 2008 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.00 | 4,537,500 | 0 | 13,612,500 | |
Apr 28 2008 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.18 | 4,125,000 | 749,925 | 12,375,000 | |
Apr 28 2008 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 4,537,500 | 1,315,875 | 4,537,500 | |
Apr 28 2008 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | M | 0.18 | 2,000,000 | 363,600 | 14,381,925 | 12.4 M to 14.4 M (+16.15 %) |
Oct 25 2007 | BCLI | BRAINSTORM CELL TH ... | Efrati Abraham | Chief Executive Off ... | Option Exercise | A | 0.87 | 1,000,000 | 870,000 | 1,000,000 | |
Nov 16 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.00 | 4,537,500 | 0 | 18,150,000 | |
Nov 16 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.18 | 4,125,000 | 749,925 | 16,500,000 | |
Nov 16 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.29 | 2,016,667 | 584,833 | 2,016,667 | |
Nov 16 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.20 | 2,520,833 | 504,167 | 2,520,833 | |
Nov 16 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | M | 0.18 | 4,125,000 | 749,925 | 12,381,925 | 8.3 M to 12.4 M (+49.96 %) |
Oct 25 2007 | BCLI | BRAINSTORM CELL TH ... | GREENFIELD MICHAEL D | Payment of Exercise | F | 0.00 | 100,000 | 0 | 300,000 | 400 K to 300 K (-25.00 %) | |
Oct 25 2007 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | F | 0.15 | 100,000 | 15,000 | 0 | |
Oct 25 2007 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Payment of Exercise | F | 0.00 | 100,000 | 0 | 300,000 | 400 K to 300 K (-25.00 %) |
Sep 17 2007 | BCLI | BRAINSTORM CELL TH ... | TEL AVIV UNIVERSITY | 10% Owner | Option Exercise | S | 0.01 | 3,181,925 | 31,819 | 3,181,924 | |
Sep 11 2007 | BCLI | BRAINSTORM CELL TH ... | TEL AVIV UNIVERSITY ECONOMIC C ... | 10% Owner | Option Exercise | S | 0.01 | 3,181,925 | 31,819 | 3,181,924 | |
Sep 11 2007 | BCLI | BRAINSTORM CELL TH ... | RAMOT AT TEL AVIV UNIVERSITY L ... | 10% Owner | Option Exercise | S | 0.01 | 3,181,925 | 31,819 | 3,181,924 | |
Sep 10 2007 | BCLI | BRAINSTORM CELL TH ... | Javitt Jonathan C | Director | Option Exercise | P | 0.01 | 1,000,000 | 10,000 | 1,000,000 | |
Sep 10 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.00 | 3,181,925 | 0 | 0 | |
Sep 10 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.01 | 1,181,925 | 11,819 | 1,181,925 | |
Sep 10 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.01 | 1,181,925 | 11,819 | 0 | |
Sep 10 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | M | 11,819.00 | 1,181,925 | 13,969,171,575 | 8,256,925 | 7.1 M to 8.3 M (+16.71 %) |
Aug 30 2007 | BCLI | BRAINSTORM CELL TH ... | Javitt Jonathan C | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.00 | 7,562,500 | 0 | 22,687,500 | |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.18 | 6,875,000 | 1,249,875 | 20,625,000 | |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | M | 0.20 | 7,562,500 | 1,512,500 | 7,562,500 | |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | M | 0.18 | 6,875,000 | 1,249,875 | 7,075,000 | 200 K to 7.1 M (+3,437.50 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.07 | 4,500 | 4,815 | 7,075,000 | 7.1 M to 7.1 M (+0.06 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.06 | 20,500 | 21,724 | 7,075,000 | 7.1 M to 7.1 M (+0.29 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.08 | 20,500 | 22,134 | 7,075,000 | 7.1 M to 7.1 M (+0.29 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.05 | 29,500 | 30,948 | 7,075,000 | 7 M to 7.1 M (+0.42 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.05 | 16,000 | 16,800 | 7,075,000 | 7.1 M to 7.1 M (+0.23 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 0.97 | 20,500 | 19,809 | 7,075,000 | 7.1 M to 7.1 M (+0.29 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.00 | 13,500 | 13,500 | 7,075,000 | 7.1 M to 7.1 M (+0.19 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.01 | 66,500 | 67,165 | 7,075,000 | 7 M to 7.1 M (+0.95 %) |
Aug 17 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Buy | P | 1.02 | 8,500 | 8,710 | 7,075,000 | 7.1 M to 7.1 M (+0.12 %) |
Jul 18 2007 | BCLI | BRAINSTORM CELL TH ... | Lion Moshe | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
Aug 08 2007 | BCLI | BRAINSTORM CELL TH ... | ACCBT Corp. | 10% Owner | Option Exercise | P | 636,385.00 | 3,181,925 | 2,024,929,341,125 | 3,181,925 | |
Jul 16 2007 | BCLI | BRAINSTORM CELL TH ... | ARBEL IRIT | Director | Option Exercise | A | 0.15 | 100,000 | 15,000 | 100,000 | |
Jul 16 2007 | BCLI | BRAINSTORM CELL TH ... | SHORR ROBERT G L | Director | Grant | A | 0.00 | 100,000 | 0 | 400,000 | 300 K to 400 K (+33.33 %) |
Jul 16 2007 | BCLI | BRAINSTORM CELL TH ... | GREENFIELD MICHAEL D | Director | Grant | A | 0.00 | 100,000 | 0 | 400,000 | 300 K to 400 K (+33.33 %) |
Mar 23 2007 | BCLI | BRAINSTORM CELL TH ... | STOLICK DAVID | Chief Financial Off ... | Option Exercise | A | 0.47 | 350,000 | 164,500 | 350,000 |